US0956333019 - Common Stock
BLUEJAY DIAGNOSTICS INC
NASDAQ:BJDX (5/3/2024, 7:00:01 PM)
0.547
+0.02 (+3.21%)
Bluejay Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Acton, Massachusetts and currently employs 16 full-time employees. The company went IPO on 2021-11-10. Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a near-patient testing system for triage and monitoring of disease progression. The firm's Symphony platform is a technology platform that provides measurements of key diagnostic biomarkers found in whole blood. The Symphony analyzer orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The firm's first product candidate, an IL-6 test for sepsis triage, is designed to provide results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and better triage/treatment decisions. The Symphony platform and its initial biomarker test, Symphony IL-6 test, is suited to address a subset of the global in vitro diagnostics devices (IVDs) market, including sepsis, cardio-metabolic diseases, cancer, and other diseases that require rapid tests.
BLUEJAY DIAGNOSTICS INC
360 Massachusetts Avenue, Suite 203
Acton MASSACHUSETTS
P: 19786310152
Employees: 16
Website: https://bluejaydx.com/
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning!
BJDX stock results show that Bluejay Diagnostics missed analyst estimates for earnings per share the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bluejay Diagnostics (NASDAQ:BJDX) just reported results for the fourth quarter ...
It's time for a breakdown of the biggest pre-market stock movers for Wednesday morning as we check out all of the latest news today!
ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company...
ACTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company...
Here you can normally see the latest stock twits on BJDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: